Kristin Abate, CAO of Karyopharm Therapeutics KPTI, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $9,975. The latest trade was on 05/14.

KA

KA

Kristin Abate

Chief Accounting Officer

Company

Karyopharm Therapeutics KPTI

First filing

25/03/04

Trades

15 trades

Buys / sales

0 / 9

12-month net buying

−$9,975

Last trade

05/14

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Karyopharm TherapeuticsKPTI	Open-market sale	05/14	05/15	53 sh	$9.50	$503.5	−0.2%
Karyopharm TherapeuticsKPTI	Open-market sale	03/02	03/03	559 sh	$9.41	$5,260.19	−2.5%
Karyopharm TherapeuticsKPTI	Open-market sale	01/28	01/29	50 sh	$7.03	$351.5	−0.2%
Karyopharm TherapeuticsKPTI	Open-market sale	01/21	01/22	265 sh	$5.96	$1,579.4	−1.2%
Karyopharm TherapeuticsKPTI	Open-market sale	25/10/01	25/10/03	362 sh	$6.30	$2,280.6	−3.5%
Karyopharm TherapeuticsKPTI	Open-market sale	25/09/15	25/09/16	23 sh	$6.43	$147.89	−0.2%
Karyopharm TherapeuticsKPTI	Open-market sale	25/09/03	25/09/04	12 sh	$6.78	$81.36	−0.1%
Karyopharm TherapeuticsKPTI	Open-market sale	25/07/22	25/07/23	238 sh	$4.00	$952	−2.5%
Karyopharm TherapeuticsKPTI	Open-market sale	25/03/04	25/03/06	571 sh	$6.29	$3,591.59	−5.6%